Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value: $321M (100.0% shares, 0.0% debt)

Holdings (22)

ACRS Aclaris therapeutics 33.5%

Value $107M Shares 4,191,397 Est. Cost $19.11 Unrealized +11.0%

ASND Ascendis Pharma 11.1%

Value $35.51M Shares 1,766,832 Est. Cost $17.51 Unrealized —

— Eiger BioPharmaceuticals 7.5%

Value $23.93M Shares 1,787,091 Est. Cost $16.42 Unrealized —

CDXS Codexis, Inc. 7.3%

Value $23.51M Shares 5,294,825 Est. Cost $3.85 Unrealized +8.9%

— Nabriva Therapeutics AG 6.9%

Value $22.22M Shares 3,151,700 Est. Cost $8.96 Unrealized —

— Advanced Accelerator Applications S.A. 5.4%

Value $17.36M Shares 455,798 Est. Cost $35.02 Unrealized —

— Agile Therapeutics, Inc. 4.4%

Value $14.1M Shares 2,019,955 Est. Cost $6.21 Unrealized —

RGNX Regenxbio Inc. 4.3%

Value $13.88M Shares 990,449 Est. Cost $12.80 Unrealized -13.8%

— Trevena, Inc. 3.6%

Value $11.66M Shares 1,728,000 Est. Cost $7.67 Unrealized —

— Aimmune Therapeutics, Inc. 3.6%

Value $11.45M Shares 763,009 Est. Cost $10.82 Unrealized —

— CoLucid Pharmaceuticals, Inc. 2.7%

Value $8.584M Shares 225,000 Est. Cost $38.15 Unrealized —

— Foamix Pharmaceuticals Ltd. 2.5%

Value $7.917M Shares 855,000 Est. Cost $9.26 Unrealized —

— Capnia, Inc. 2.1%

Value $6.711M Shares 7,456,984 Est. Cost $1.19 Unrealized —

— Akari Therapeutics Plc 1.4%

Value $4.492M Shares 527,842 Est. Cost $14.00 Unrealized —

— ProNAi Therapeutics, Inc. 1.4%

Value $4.438M Shares 2,438,270 Est. Cost $6.74 Unrealized —

— Dynavax Technologies Corporation 1.2%

Value $3.775M Shares 359,828 Est. Cost $19.24 Unrealized —

— Carbylan Therapeutics 0.6%

Value $1.934M Shares 4,204,562 Est. Cost $0.64 Unrealized —

— ReVance Therapeutics, Inc. 0.4%

Value $1.254M Shares 77,373 Est. Cost $24.38 Unrealized —

— Ocera Therapeutics, Inc. 0.1%

Value $405K Shares 153,331 Est. Cost $2.94 Unrealized —

— Capnia, Inc. 0.1%

Value $198K Shares 943,858 Est. Cost $0.23 Unrealized —

— Palatin Technologies, Inc. 0.0%

Value $148K Shares 234,909 Est. Cost $0.54 Unrealized —

— Zosano Pharma Corp 0.0%

Value $78,000 Shares 98,515 Est. Cost $2.30 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris therapeutics	4,191,397	$107M	33.5%	$19.11	+11.0%	Common	00461U105
ASND	Ascendis Pharma	1,766,832	$35.51M	11.1%	$17.51	—	ADR	04351P101
—	Eiger BioPharmaceuticals	1,787,091	$23.93M	7.5%	$16.42	—	Common	28249U105
CDXS	Codexis, Inc.	5,294,825	$23.51M	7.3%	$3.85	+8.9%	Common	192005106
—	Nabriva Therapeutics AG	3,151,700	$22.22M	6.9%	$8.96	—	ADR	62957M104
—	Advanced Accelerator Applications S.A.	455,798	$17.36M	5.4%	$35.02	—	Common	00790T100
—	Agile Therapeutics, Inc.	2,019,955	$14.1M	4.4%	$6.21	—	Common	00847L100
RGNX	Regenxbio Inc.	990,449	$13.88M	4.3%	$12.80	-13.8%	Common	75901B107
—	Trevena, Inc.	1,728,000	$11.66M	3.6%	$7.67	—	Common	89532E109
—	Aimmune Therapeutics, Inc.	763,009	$11.45M	3.6%	$10.82	—	Common	00900T107
—	CoLucid Pharmaceuticals, Inc.	225,000	$8.584M	2.7%	$38.15	—	Common	19716T101
—	Foamix Pharmaceuticals Ltd.	855,000	$7.917M	2.5%	$9.26	—	Common	M46135105
—	Capnia, Inc.	7,456,984	$6.711M	2.1%	$1.19	—	Common	14066L105
—	Akari Therapeutics Plc	527,842	$4.492M	1.4%	$14.00	—	ADR	00972G108
—	ProNAi Therapeutics, Inc.	2,438,270	$4.438M	1.4%	$6.74	—	Common	74346L101
—	Dynavax Technologies Corporation	359,828	$3.775M	1.2%	$19.24	—	Common	268158201
—	Carbylan Therapeutics	4,204,562	$1.934M	0.6%	$0.64	—	Common	141384107
—	ReVance Therapeutics, Inc.	77,373	$1.254M	0.4%	$24.38	—	Common	761330109
—	Ocera Therapeutics, Inc.	153,331	$405K	0.1%	$2.94	—	Common	67552A108
—	Capnia, Inc.	943,858	$198K	0.1%	$0.23	—	Warrant	14066L113
—	Palatin Technologies, Inc.	234,909	$148K	0.0%	$0.54	—	Common	696077403
—	Zosano Pharma Corp	98,515	$78,000	0.0%	$2.30	—	Common	98979H103